Iris Vascular Area Density-Based Preoperative Pain-Risk Screening and Intervention in Second-Eye Cataract Surgery
Key facts
- Who runs it
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 126 people enrolled
- Started
- 23 Feb 2024
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Pranoprofen eye drops
- Prednisolone acetate eye drops
- Sodium hyaluronate eye drops
- Record updated
- 24 February 2026
Who can take part
- Age
- 50 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Aged ≥ 50 years
- Definite diagnosis of age-related cataract
- The first-eye cataract surgery under local anesthesia has been completed at this hospital, and the second-eye cataract surgery under local anesthesia is planned with the same surgeon within 1 year of the first-eye surgery
- Able to cooperate with preoperative iris optical coherence tomography angiography (OCTA) examination of the operative eye
- On the day of the second-eye surgery, preoperative iris vascular area density (VAD) ≥ 0.2167 in the operative eye
Who cannot take part
- Severe complications during or after the first-eye surgery (e.g., posterior capsule rupture, zonular dialysis, dislocation of the lens nucleus into the vitreous cavity, postoperative endophthalmitis, or glaucoma)
- Long-term use of opioids, other systemic analgesics, or sedative-hypnotic drugs
- Use of topical corticosteroid eye drops in the second eye within 1 month prior to the planned surgery
- Participation in any other clinical trial involving ophthalmic or systemic drugs within the past 6 months
- History of ocular trauma, ocular surgery (excluding the first-eye cataract surgery already performed), uveitis, chorioretinal disease, glaucoma
- Presence of significant corneal disease, marked iris abnormalities, or any active ocular surface disease, including recent conjunctivitis, keratitis, or severe dry eye
- History of chronic pain syndromes or neuropathic pain
- Known autoimmune disease or ongoing immunosuppressive therapy
- Severe psychiatric disorders or cognitive impairment interfering with pain assessment
- Long-term use of α-adrenergic blockers or other medications associated with intraoperative floppy iris syndrome (IFIS)
- Known allergy or contraindication to topical nonsteroidal anti-inflammatory drugs (NSAIDs) (e.g., pranoprofen) or topical corticosteroids (e.g., prednisolone acetate) used in this study
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This clinical trial aims to evaluate the effectiveness of pranoprofen or prednisolone acetate eye drops for pain management in patients undergoing second-eye surgery for age-related cataracts. Researchers will compare pranoprofen or prednisolone acetate eye drops with sodium hyaluronate eye drops to determine whether pranoprofen or prednisolone acetate eye drops can relieve intraoperative pain during second-eye cataract surgery.
Read full original descriptionShow less
Participants will:
1. Receive one drop in the operative eye at 2 hours, 1.5 hours, 1 hour, and 30 minutes before cataract surgery (pranoprofen, prednisolone acetate, or sodium hyaluronate) 2. Undergo cataract surgery and routine postoperative follow-up 3. Within 1 hour after surgery, provide a pain visual analog scale (VAS) score under the guidance of the investigator
The 3 groups in the trial
- Pranoprofen ophthalmic solution groupTreatment being tested
Treatment: Pranoprofen eye drops
- Prednisolone acetate ophthalmic suspension groupTreatment being tested
Treatment: Prednisolone acetate eye drops
- Sodium hyaluronate ophthalmic solution groupPlacebo, for comparison
Treatment: Sodium hyaluronate eye drops
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Preoperative Pain-Risk Screening and Intervention for Intraoperative Pain in Second-Eye Cataract Surgery Based on Iris Vascular Area Density
- Record updated
- 24 February 2026